Matthew Shea
Stock Analyst at Needham
(2.76)
# 3,506
Out of 5,182 analysts
7
Total ratings
71.43%
Success rate
24.87%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Matthew Shea
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASTH Astrana Health | Maintains: Buy | $30 → $41 | $39.30 | +4.33% | 2 | May 8, 2026 | |
| EVH Evolent Health | Maintains: Buy | $4 → $5 | $4.18 | +19.62% | 2 | May 7, 2026 | |
| TOI The Oncology Institute | Reiterates: Buy | $5 | $4.00 | +25.00% | 3 | Mar 13, 2026 |
Astrana Health
May 8, 2026
Maintains: Buy
Price Target: $30 → $41
Current: $39.30
Upside: +4.33%
Evolent Health
May 7, 2026
Maintains: Buy
Price Target: $4 → $5
Current: $4.18
Upside: +19.62%
The Oncology Institute
Mar 13, 2026
Reiterates: Buy
Price Target: $5
Current: $4.00
Upside: +25.00%